What is the recommended dosing of mebendazole 500 mg for treating common soil‑transmitted helminth infections such as Ascaris, hookworm, Trichuris, and Enterobius?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Mebendazole 500mg Dosing for Parasitic Infections

For common soil-transmitted helminth infections, mebendazole 500 mg should be given as a single oral dose for Ascaris lumbricoides, hookworm, and as part of empirical treatment regimens, but requires 100 mg twice daily for 3 days (combined with ivermectin) for Trichuris trichiura due to its lower single-dose efficacy against whipworm. 1

Specific Dosing by Parasite

Ascaris lumbricoides (Roundworm)

  • Single dose of 500 mg orally 1
  • This achieves excellent cure rates of 92.6% (range 72.5-100%) and egg reduction rates of 97.9% 2
  • The FDA-labeled regimen of 100 mg twice daily for 3 days achieves 98% cure rates 3

Hookworm (Ancylostoma duodenale, Necator americanus)

  • Single dose of 500 mg orally 1
  • However, efficacy is notably lower than for Ascaris: cure rates only 25.5% (range 2.9-91.1%) and egg reduction rates 72% 2
  • Important caveat: Albendazole 400 mg daily for 3 days is superior for hookworm (cure rate 92% vs 54% for mebendazole triple-dose) 4
  • Consider albendazole as first-line for hookworm when available

Trichuris trichiura (Whipworm)

  • 100 mg twice daily for 3 days PLUS ivermectin 200 μg/kg once daily for 3 days 1
  • Single 500 mg dose has poor efficacy: only 27.6% cure rate 2
  • The combination therapy improves cure rates substantially (up to 71% with triple-dose mebendazole) 4

Enterobius vermicularis (Pinworm)

  • Single dose of 500 mg orally (equivalent to the FDA-labeled 100 mg single dose) 3
  • Achieves 95% cure rates 3
  • Repeat dose in 2 weeks if not cured 3

Alternative Regimens

Empirical treatment for asymptomatic eosinophilia (when specific parasite unknown):

  • Single dose albendazole 400 mg PLUS single dose ivermectin 200 μg/kg 1
  • Critical warning: Exclude Loa loa infection before giving ivermectin in patients from endemic regions (Central/West Africa)

Administration Details

  • The 500 mg tablet can be chewed, swallowed whole, or crushed and mixed with food 3
  • No fasting or purging required 3
  • For young children (≥1 year), the tablet can be rapidly disintegrated with small amount of water on a spoon 5

Key Clinical Pitfalls

  1. Hookworm resistance concern: Studies from areas with repeated mebendazole treatment show declining efficacy against hookworm (cure rates dropping from 22.4% to 7.6%) 6. Consider albendazole as first-line for hookworm.

  2. Whipworm requires multi-day therapy: Single-dose 500 mg mebendazole is inadequate for T. trichiura. The combination with ivermectin is essential 1.

  3. Mixed infections are common: When treating empirically or when multiple parasites are present, consider that single-dose 500 mg works well for Ascaris and pinworm but poorly for hookworm and whipworm 2, 7.

  4. Follow-up timing: Assess treatment efficacy 14-21 days post-treatment for optimal egg count assessment 8.

  5. Pregnancy considerations: While the guidelines don't explicitly contraindicate mebendazole in pregnancy, the drug label notes very low excretion in breastmilk, making it likely compatible with breastfeeding 1.

Evidence Quality Note

The 2025 UK guidelines 1 represent the most current expert consensus, supported by FDA labeling 3 and recent systematic reviews 2, 7. The single 500 mg dose represents a simplified regimen equivalent to the traditional 100 mg twice daily dosing, designed for mass drug administration programs 5.

References

Research

Development of a new age-appropriate, chewable tablet of mebendazole 500 mg for preventive chemotherapy of soil-transmitted helminth infections in pre-school and school-age children.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.